Curaderm-BEC5 Natural Non-Invasive Medication for Skin Cancer
Curaderm-BEC5’s ease of use, cost-effectiveness, proven efficacy and safety represent a significant breakthrough in the treatment of a majority of skin carcinomas, by far the most common form of cancer which is normally triggered by over exposure to the sun. The Skin Cancer Cream has been documented in hundreds of Medical & Scientific Publications and two featured books about the cream formulation by the inventor Dr. Bill Elliot Cham.
Dr. Bill Cham’s two books, available via Health Book Sellers and Amazon.com.
Curaderm-bec5 Natural Non-Invasive Medication for Skin Cancer. Biopsy and 5 Year Cancer-Free Criteria.
The book explains how Curaderm is a product that has shown to be very effective in trating lesions of the skin such as Actinic Keratosis (AK), Keratoacanthoma (KA) and the nonmelanoma skin cancers Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC)
Inspired by Nature Proven By Science. The new generation cancer treatment that causes cancer cells to commit suicide.
A unique case is presented that gives a direct comparison of surgical treatment and CuradermBEC5 therapy in a patient with skin cancers on the head. The book also contains a photo gallery section of CuradermBEC5 treated skin cancer patients. This book consists of 265 pages and contains 479 illustrations. Editorial Reviews: Professor Cham’s research can change the treatment of cancer in a fundamental way.
His research has stimulated worldwide interest in the clinical application of solasodine glycosides for the treatment of cancer. Studies that confirm his findings have been published by researchers in Asia, especially China, the United Kingdom and the United States. -Leo Galland, M.D., Director, Foundation for Integrated Medicine, New York, USA Dr Cham has found substances which can penetrate and kill cancer cells but can’t penetrate normal cells, so normal cells are untouched and unhurt while the cancer cells die! If anyone deserves a Nobel Prize in Medicine, it’s Dr. Bill E Cham. -Jonathan V. Wright, M.D., Medical Director, Tahoma Clinic & Tahoma Foundation, Tukwila, Washington, USA
Curaderm-BEC5 Skin Cancer Cream
Clinical Trials
Numerous clinical trials in Australia and Great Britain have confirmed BEC5’s ability to regress non-melanoma skin cancers. In one open study with 72 patients, treatment with BEC5 cream resulted in the regression of all treated lesions (56 actinic keratoses, 39 BCCs and 29 SCCs), with 100% healed after 1 to 13 weeks of treatment.
Recent trials in 10 UK hospitals found that a twice daily topical application of BEC5 cream to the affected areas gave a complete remission to 78% of the patients within 8-weeks. The remaining 22% of patients had also improved and needed longer treatment times, all this was made possible without chemotherapy, radiotherapy or surgery. The dermatologists at the Royal London Hospital concluded that: “BEC5 is a topical preparation which is safe and effective, an ideal therapy for outpatient treatment… It is a cost effective treatment for both primary and secondary skin cancer care. Furthermore, the histological analyses of biopsies taken before, during and after treatment give compelling evidence of the continuing efficacy of BEC5 because treated skin cancer lesions have not recurred for at least 5 years after cessation of therapy”
Curaderm-BEC5, is a topical cream preparation of a mixture of the natural glycoalkaloids extract solasodine glycosides (BEC). BECs are present in some solanaceous plants, including edible plants such as Solanum melongena (otherwise known as eggplant or aubergine). Now, BEC is available to the public for the treatment of cutaneous solar keratosis, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). These are known as Non Melanoma Skin cancers.
NOTE: Curaderm-BEC5 is formulated for Non-Melanoma skin cancers and should NOT be used on Melanoma.
Curaderm skin cancer cream achieves total removal of all Sun spots, Keratosis, Squamous cell carcinoma and Basal cell carcinoma. These non-melanoma skin cancers represent 90% of all skin cancers. In addition, it has also been shown to be efficacious with benign tumours, including keratoses, keratoacanthomas, sun spots and age spots.
Curaderm BEC5 cream contains a plant sugar called rhamnose (not usually found in mammals) which penetrates the skin, targets the cancerous cells and kills them. The active ingredient does not penetrate healthy cells, leaving them to multiply and replace the dead cancerous cells, the skin heals. The cream can also be used as a pre-emptive measure. Applying it sparingly twice a day to a sun spot will prevent cancer lesions from developing. The cream is not at all toxic, so it can be applied over the face, (avoiding the eyes) arms and other potential skin cancer/sun spot risk areas as a preventative measure.
The skin cancer cream mechanism of action is different and allows it to kill cancer cells, and only cancer cells, regardless of whether they are dividing or “resting”. Cancer cells have large numbers of a specific receptor on their surface that recognizes and binds BEC, which is then drawn inside the cancer cell and taken up by its “stomach” (lysosomes). When the lysosomes digest BEC, solasodine is generated and causes the lysosome to rupture, spilling its contents—digestive enzymes—into the cell. The cancer cell’s own digestive enzymes then proceed to digest the cell, causing its death through apoptosis (more like an organized disassembly process than a death). The fact that BEC kills cancer cells by triggering the natural process of apoptosis is key to its elegance: BEC preserves the natural healing processes for rebuilding the normal tissue that was lost to the cancer.
Normal cells either completely lack this receptor or have only an extremely small amount of it, so BEC cannot attach to normal cells.
The naturally occurring glycoalkaloids solasodine glycosides (BEC) have anticancer activity in cell culture, animals and in humans. Specific endogenous lectins which are present in the plasma membranes of cancer cells recognize and bind the sugar moiety of BEC. BEC is subsequently internalised and causes cell death by destroying the lysosome. This mode of action is very different than with other anticancer drugs (which are non-specific, destroying normal cells as well) and work on the nuclear contents such as the DNA or RNA of cells.
Independent centres show that Curaderm-BEC5 is virtually 100% effective for treating skin cancers if the lesions are treated for long enough.
The cosmetic result of skin cancer cream treatment with Curaderm-BEC5 is excellent.
Lesions treated appropriately with Curaderm-BEC5 result in no recurrence.
The amount of BEC in Curaderm is very small. One average-sized egg plant fruit (300g) contains the same amount of BEC as 60 tubes of Curaderm! Thus, Curaderm-BEC cream is safe as shown by the many published studies.
Curaderm-BEC5 is an ideal therapy for non-melanoma skin cancers Basal Cell Carcinoma, Squamous Cell Carcinoma and Keratosis and sunspots.
Buy Curaderm-BEC5 on Secure Server Store for World-Wide Delivery
The treatment of Choice for Actinic keratoses, Basal cell carcinoma, Squamous cell carcinoma.
Curaderm-BEC5 Topical cream
Curaderm-BEC5 has recorded over 100,000 successful and safe removals. The main advantages of Curaderm-BEC5 being:
1. The BEC5 active, patented since the early 1980’s is Cancer specific technology that identifies and eliminates only the cancerous growths within the skin dermis. Research Phase 3 and 4 clinical trials released in 2002 by Royal London Hospital (UK) and ten Skin cancer clinics confirmed the specific cancer removing technology advantages over all other treatments.
2. Healthy skin tissue around the cancer cells are maintained and the BEC5 protects the healthy skin cells so that once cancer is gone, the healthy cells multiply so normal beautiful skin tissue is quickly and easily restored.
3. Because the BEC5 keeps tracking and tracking then destroying all the cancer cells one by one, to the millions! Cancer cells always, by definition, clump together and line up in rows, multiplying and taking over the space of healthy cells. Because BEC5 traces them all the way, the eye does not need to see and scrape out the cancer cells as with surgery. The fact that every cancer cell is removed in the Curaderm-BEC5 process means there is no chance of recurrence! This is an unquestionable advantage as every other treatment except Curaderm-BEC5 does incur returned skin cancers after failed treatments up to 30% of the time.
4. Curaderm-BEC5 Treatments do not require any post treatment medical operation such as reconstructive surgery, plastic surgery, skin grafting, injections or any other such medical operations.
Curaderm’s mechanism of action is different and allows it to kill cancer cells, and only cancer cells.
Other anti-cancer drugs kill cells by interfering with mitosis, the process through which cells divide and replicate. Cancer cells undergo mitosis much more frequently than normal cells, so killing all dividing cells causes the death of many more cancerous than normal cells, but these drugs kill not only cancer cells, but also normal cells while they are dividing.
Curaderm’s mechanism of action is different and allows it to kill cancer cells, and only cancer cells, regardless of whether they are dividing or “resting”. Cancer cells have large numbers of a specific receptor on their surface that recognizes and binds BEC, which is then drawn inside the cancer cell and taken up by its “stomach” (lysosomes). When the lysosomes digest BEC, solasodine is generated and causes the lysosome to rupture, spilling its contents—digestive enzymes—into the cell. The cancer cell’s own digestive enzymes then proceed to digest the cell, causing its death through apoptosis (more like an organized disassembly process than a death). The fact that BEC kills cancer cells by triggering the natural process of apoptosis is key to its elegance: BEC preserves the natural healing processes for rebuilding the normal tissue that was lost to the cancer.
Normal cells either completely lack this receptor or have only an extremely small amount of it, so BEC cannot attach to normal cells.
The treatment of Choice for Actinic keratoses, Basal cell carcinoma, Squamous cell carcinoma.
Information on this site is provided for informational purposes and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease, or prescribing any medication. Statements have not been evaluated by the Food and Drug Administration and we make no claims as to the efficacy or value for money provided by Curaderm and instead prefer to let customers speak for themselves.